Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $18.40 USD
Change Today +0.24 / 1.32%
Volume 17.8M
BSX On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

300 Boston Scientific Way

Marlborough, MA 01752

United States

Phone: 508-683-4000

Fax:

e of ACUITY X4 quadripolar LV leads, and the ACUITY PRO lead delivery system. At the same time, the company received CE Mark for a new MINI line and a new EL (extended longevity) line of ICDs. Additionally, DYNAGEN X4, INOGEN X4, DYNAGEN MINI, and INOGEN MINI were FDA approved and launched in the U.S. in 2014, while the EL line was launched in the U.S. in 2015. Electrophysiology Within the company’s Electrophysiology business, it develops less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart. Included in the company’s product offerings are steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. The company’s products include the Blazer line of temperature ablation catheters, designed to deliver improved performance and responsiveness. The company’s cooled ablation portfolio includes its closed-loop irrigated catheter, the Chilli II cooled ablation catheter, and CE Mark approved Blazer Open-Irrigated ablation catheter with a Total Tip Cooling Design. The company’s diagnostic catheter portfolio includes Blazer Dx-20, Dynamic Tip, and Viking catheters. In 2013, the company received FDA approval for the IntellaTip MiFi XP catheter, with MicroFidelity sensor technology, representing a new generation of high-resolution ablation catheters for the treatment of atrial flutter. The company has a capital equipment product offering, including its LabSystem Pro Recording System, the Rhythmia Mapping System, Maestro radio frequency generators, and the MetriQ pump (CE Mark approved). MedSurg Endoscopy Gastroenterology The company is dedicated to transforming the lives of patients by advancing the diagnosis and treatment of a range of pulmonary and gastrointestinal (GI) conditions with less invasive technologies. Common disease states include esophageal disorders, GI strictures and bleeding, biliary disease, and conditions, as well as esophageal, biliary, pancreatic, and colon cancer. Some of the company’s product offerings comprise: The company’s Spyglass System, which is the first and only single-operator cholangioscopy system that offers clinicians direct visualization of the pancreatico-biliary system and includes therapeutic devices for managing biliary stones and strictures. The company’s WallFlex Colonic Stents, which have been shown to reduce patient postoperative length of stay. The company’s WallFlex Biliary RX Stents provide relief for pancreatic cancer patients receiving chemotherapy before undergoing surgery through pre-operative drainage of the bile duct. The company’s WallFlex Esophageal Stents deliver luminal patency in patients with esophageal strictures. The company’s Resolution Clip, a technology used to provide hemostasis and closure within the GI System. The company’s Expect Aspiration Needle, which is a needle used with endoscopic ultrasound enabling physicians to target and sample lesions in the GI system with a high degree of accuracy. The company’s line of RX Biliary System devices that are designed to provide access and control for physicians to diagnose and treat challenging conditions of the bile ducts, such as removing gallstones, opening obstructed bile ducts, and obtaining biopsies in suspected tumors. Interventional Bronchoscopy The company markets devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs. The company’s products are designed to help perform biopsies, retrieve foreign bodies from the airway, open narrowings of an airway, stop internal bleeding, and ease symptoms of some types of airway cancers. The company’s product line includes pulmonary biopsy forceps, transbronchial aspiration needles, cytology brushes, and tracheobronchial stents used to dilate narrowed airway passages or for tumor management. The company owns Asthmatx, Inc. (Asthmatx), which added to its Endoscopy portfolio a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma. The Alair Bronchial Thermoplasty System, developed by Asthmatx, has CE Mark, Chin

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BSX:US $18.40 USD +0.24

BSX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Becton Dickinson and Co $141.53 USD -0.86
Olympus Corp ¥4,390 JPY -50.00
St Jude Medical Inc $67.76 USD -0.52
Stryker Corp $92.50 USD +0.32
Zimmer Holdings Inc $114.61 USD -0.75
View Industry Companies
 

Industry Analysis

BSX

Industry Average

Valuation BSX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.3x
Price/Book 3.8x
Price/Cash Flow 77.2x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOSTON SCIENTIFIC CORP, please visit www.bostonscientific.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.